By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Teva Neuroscience, Inc. 

901 E. 104th Street
Suite 900
Kansas City  Missouri  64131  U.S.A.
Phone: 800-221-4026 or 816-508-5000
Fax: 816-508-5016


SEARCH JOBS


Industry
Pharmaceutical






Company News
Topin & Associates Selects an Account Supervisor to Manage Teva Neuroscience, Inc. (TEVA)'s Global Brand 12/3/2012 11:25:35 AM
Teva Neuroscience, Inc. (TEVA) Will Take 100 Jobs from KC to OP 4/5/2012 7:27:45 AM
Teva Neuroscience, Inc. (TEVA) Release: Recently Published Clinical Pharmacology Study Confirms Azilect(R) Selectively Inhibits MAO-B at Approved Doses 6/2/2010 10:29:12 AM
BioScrip (BIOS) Commences Patient Enrollment in Teva Neuroscience, Inc. (TEVA) Therapy Optimization in Multiple Sclerosis (Tops MS) Research Study 6/30/2009 9:49:30 AM
Teva Neuroscience, Inc. (TEVA): Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity 6/9/2009 11:25:23 AM
Teva Neuroscience, Inc. (TEVA) Release: COPAXONE(R) Significantly Reduced Brain Atrophy and Tissue Loss over Five Years in Treatment-Naive Relapsing-Remitting Multiple Sclerosis Patients 4/18/2008 7:46:56 AM
Teva Neuroscience, Inc. (TEVA): Study Showed Patients Using COPAXONE┬« Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif┬« in Relapsing-Remitting Multiple Sclerosis (RRMS) 10/25/2007 9:42:21 AM
Teva Neuroscience, Inc. (TEVA): New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis 10/25/2007 9:36:41 AM
Teva Neuroscience, Inc. (TEVA) Release: International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease 6/8/2007 12:58:27 PM
Treatment with Teva Neuroscience, Inc. (TEVA)'s COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis 5/4/2007 1:21:33 PM
12345
//-->